Matthew E. Monaghan - Apr 1, 2022 Form 4 Insider Report for INVACARE CORP (IVC)

Role: Chairman, President and CEO, Director
Signature: /s/ Matthew E. Monaghan, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated March 31, 2015, on file with the Commission
Stock symbol: IVC
Transactions as of: Apr 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/5/2022, 04:47 PM
Previous filing: Mar 14, 2022
Next filing: May 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IVC	Common Shares	Award	$0	+294K	+27.97%	$0.00	1.35M	Apr 1, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IVC	Employee Stock Option (Right to Buy)						400K	Apr 1, 2022	Common Shares	400K		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted shares granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in 1/3 annual increments over three years commencing on May 15, 2023.
F2	No transaction is being reported on this line. Reported on a previously filed Form 4.